Mutations contributing to clonal hematopoiesis are associated with poor prognosis in chronic ischemic heart failure

28 August 2018 (12:00 - 12:15)

Organised by:

About the speaker

Professor Birgit Assmus

Justus-Liebig University of Giessen, Giessen (Germany)

5 More presentations in this session

Presentation thumbnail

CRISPR/Cas9-mediated Disruption of the Human R14del Mutation Suppresses Arrhythmias in a Novel Humanized Mouse Model of Arrhythmogenic Cardiomyopathy

Doctor N. Raad (New York, US)

Presentation thumbnail

Impaired Excitation Contraction Coupling in Human Induced Pluripotent Stem Cell Derived Cardiac Myocytes from Arrhythmogenic Right Ventricular Cardiomyopathy Patients with a Plakophilin2 Mutation

Doctor K. Hammer (Regensburg, DE)

Presentation thumbnail

Arrhythmogenic Cardiomyopathy type 8 zebrafish models: opportunities for the identification of early pathogenetic events and new therapeutic targets

Associate Professor N. Tiso (Padova, IT)

Presentation thumbnail

BNP signal peptide protects the heart from ischemia-reperfusion injury

Professor C. Pemberton (Christchurch, NZ)

Presentation thumbnail

The SIRT1 activator resveratrol ameliorates dystrophic cardiomyopathy by promoting mitophagy.

Professor A. Kuno (Sapporo, JP)

Access the full session

Session thumbnail

Late Breaking Basic and Translational Science - Cardiac Biology

The Event

ESC Congress 2018

28 August 2018 12:00 CET

You may be interested in

Congress Session

Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives

Congress Session

Chronic kidney disease and heart failure

Congress Session

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources